PEPTIDE-TARGETED RADIOACTIVE COMPOSITE NANODEVICES TREATING PROSTATE CANCER

$604,994FY2008Department of DefenseDOD

Health Research, Inc., Rockville MD

Investigators

View source on USAspending →